Eduardo de Lima
University of Valle
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Eduardo de Lima.
Cancer | 1990
Pelayo Correa; James G. Fox; Elizabeth T. H. Fontham; Bernardo Ruiz; Youping Lin; Diego Zavala; Nancy S. Taylor; Dawn Mackinley; Eduardo de Lima; Humberto Portilla; Guillermo Zarama
This investigation examined the correlation between Helicobacter pylori (HP) infection, as reflected in immunoglobulin G serum antibodies, and the risk of gastric cancer. Serum samples were obtained from populations with contrasting gastric cancer risks. the highest prevalence of HP infection, 93%, was observed in the adult population at highest gastric cancer risk, the residents of Pasto, Colombia. in the lower risk Colombian city of Cali, a 63% overall prevalence rate was found. Both children and adults were sampled in New Orleans, Louisiana, where gastric cancer rates are high for blacks but not for whites. the prevalence of HP infection was significantly higher in black than in white adults, 70% versus 43%, P = 0.0001. A higher prevalence was also detected in black compared with white children, 49% versus 32%, P = 0.01; however, an even greater disparity was noted when comparing children from two hospitals, regardless of race, which serve different socioeconomic groups. A prevalence rate of 54% was found at Charity Hospital compared with 24% (P = 0.0001) at Childrens Hospital. Our findings indicate that socioeconomic conditions, known to influence gastric cancer risk, are also important determinants of HP infection.
Cancer | 2017
Andreza Almeida Senerchia; Carla Renata Pacheco Donato Macedo; Sima Ferman; Marcelo Scopinaro; Walter Cacciavillano; Erica Boldrini; Vera Lúcia Lins de Moraes; Guadalupe Rey; Claudia T. de Oliveira; Luis Castillo; Maria Tereza Almeida; Maria Luisa Borsato; Eduardo de Lima; Daniel Lustosa; Jose Henrique Silva Barreto; Tatiana El‐Jaick; Simone dos Santos Aguiar; Algemir Lunardi Brunetto; Lauro Greggiani; Hugo Cogo-Moreira; Álvaro Nagib Atallah; Antonio Sergio Petrilli
Metronomic chemotherapy (MC) consists of the administration of a low dose of chemotherapy on a daily or weekly basis without a long break to achieve an antitumoral effect through an antiangiogenic effect or stimulation of the immune system. The potential effect of MC with continuous oral cyclophosphamide and methotrexate in patients with high‐grade operable osteosarcomas (OSTs) of the extremities was investigated.
Transactions of The Royal Society of Tropical Medicine and Hygiene | 1989
Eduardo de Lima; Luis Guillermo Mayoral; Francisco Falabella; Alfredo Rengifo
Colombia Medica | 1998
Adriana Rengifo; Eduardo de Lima; Gustavo Mariño; Alfredo Rengifo; José Humberto Arango; Alberto Alzate; Fernando Tuffi García; Martha Susana Forero; Matilde de Bernal; Gloria Gamboa
Colombia Medica | 1998
Gustavo Mariño; Eduardo de Lima; Fernado Tuffi García; Carlos Cuello; Harold Cuello; Alberto Alzate
Colombia Medica | 1998
Jesús Arbey Hoyos; José Humberto Arango; Rodrigo Mayor; Gustavo Mariño; Adriana Rengifo; Eduardo de Lima
Colombia Medica | 1998
Jesús Arbey Hoyos; José Humberto Arango; Eduardo de Lima
Colombia Medica | 1998
Consuelo Santamaría; Eduardo de Lima; Jaime Holguín
Colombia Medica | 2017
Eduardo de Lima; Luis Guillermo Mayoral; Francisco Falabella; Pablo Medina
Colombia Medica | 2017
Eduardo de Lima; Carlos Manzano